Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3bkW5dA
via IFTTT